Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -2.20 | 16.31 |
| PEG Ratio (TTM) | 0.21 | -0.37 |
| P/S Ratio (TTM) | 0.28 | 2.62 |
| P/B Ratio (TTM) | 0.24 | 1.43 |
| P/FCF Ratio (TTM) | -1.75 | 6.20 |
| Price to 5YR AVG Earnings Ratio | -1.87 | 15.04 |
| Price to 5YR AVG FCF Ratio | -4.67 | 9.44 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.57% | 0.94% |
| ROE (TTM) | -10.44% | 9.32% |
| Net Profit Margin (TTM) | -13.00% | 16.39% |
| ROIC 5YR AVG | -4.27% | 17.48% |
Growth (57%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -5,125.16% | 17.21% | 17.35% |
| Revenue | -1.22% | 10.13% | 7.18% |
| Net Income | -5,032.58% | 17.83% | 12.29% |
| Cash Flow | -8.86% | 2,519.49% | 1,469.79% |
Health (23%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 12.43 |
| Quick Ratio (TTM) | N/A | 12.64 |
| D/E Ratio (TTM) | 0.96 | 1.04 |
| Interest Coverage (TTM) | 0.26 | 0.72 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | 1.14 | 0.43 |
| LTL to 5YR AVG FCF | -14.41 | 5.69 |
| Shares Outstanding Growth 5YR AVG | 5.98% | 57.94% |